Skip navigation

Navigate Disclosure Mandates and Data Sharing Expectations for Patient Privacy, Lay Summaries and Informed Consent

January 30-31, 2018
  • Philadelphia, PA

CBI’s Clinical Data Disclosure and Transparency is the most comprehensive meeting of its kind! Join your peers to discuss and disseminate aspects of required data disclosure in a time of industry reform. Spend your time with a laser focus on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.

Progressive Insights and Industry Perspectives from Disclosure and Transparency Experts:

  • Examine the impact of Title VIII of FDAAA on the industry
  • Improve your understanding for the changing European transparency landscape and what the future holds
  • Learn to strengthen partnerships with advocacy groups to improve overall patient value
  • Navigate TransCelerate’s Data Transparency Initiative to better harmonize clinical trial processes
  • Hear multi-stakeholder perspectives on documentation preparation for Policy 0070

Previous Attendee Acclaim:

Fantastic conference with very knowledgeable speakers on content. I strongly recommend this conference to new folks, as well as those already in the Pharma environment to attend so that they can have a better understanding of transparency.

Clinical Trial Transparency Coordinator, AstraZeneca

A great forum for updates and trends on the evolving trial transparency landscape and compliance.

Director, Clinical Trial Disclsoure, Sanofi

January 30-31, 2017 Philadelphia

Clinical Data Disclosure and Transparency

Navigate Disclosure Mandates and Data Sharing Expectations for Patient Privacy, Lay Summaries and Informed Consent

CBI’s Clinical Data Disclosure and Transparency is the most comprehensive meeting of its kind! Join your peers to discuss and disseminate aspects of required data disclosure in a time of industry reform. Spend your time with a laser focus on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.

Progressive Insights and Industry Perspectives from Disclosure and Transparency Experts:

  • Examine the impact of Title VIII of FDAAA on the industry
  • Improve your understanding for the changing European transparency landscape and what the future holds
  • Learn to strengthen partnerships with advocacy groups to improve overall patient value
  • Navigate TransCelerate’s Data Transparency Initiative to better harmonize clinical trial processes
  • Hear multi-stakeholder perspectives on documentation preparation for Policy 0070

Previous Attendee Acclaim:

Fantastic conference with very knowledgeable speakers on content. I strongly recommend this conference to new folks, as well as those already in the Pharma environment to attend so that they can have a better understanding of transparency.

Clinical Trial Transparency Coordinator, AstraZeneca

A great forum for updates and trends on the evolving trial transparency landscape and compliance.

Director, Clinical Trial Disclsoure, Sanofi

January 30-31, 2017 Philadelphia